CN102630754A - Compound liquid dairy product with function of assisting in reducing blood fat and preparation method thereof - Google Patents
Compound liquid dairy product with function of assisting in reducing blood fat and preparation method thereof Download PDFInfo
- Publication number
- CN102630754A CN102630754A CN2012101126756A CN201210112675A CN102630754A CN 102630754 A CN102630754 A CN 102630754A CN 2012101126756 A CN2012101126756 A CN 2012101126756A CN 201210112675 A CN201210112675 A CN 201210112675A CN 102630754 A CN102630754 A CN 102630754A
- Authority
- CN
- China
- Prior art keywords
- essence
- weight portion
- compound liquid
- diary product
- liquid diary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a compound liquid dairy product with the function of assisting in reducing blood fat and a preparation method thereof, particularly relates to a diary product which meets the state relative requirements of the function of assisting in reducing blood fat of health food and a preparation method thereof and more particularly relates to a diary product which takes phytosterol ester and linolenic acid oil as a compound preparation to reach blood fat reducing function and a preparation method thereof, belonging to the technical field of food. The liquid diary product disclosed by the invention comprises the following raw materials in parts by weight: 300.0-996.0 parts of cow milk, 1.5-8.0 parts of phytosterol ester, 2.0-6.0 parts of linolenic acid oil, 0-3.0 parts of antioxidant, 0.3-3.0 parts of emulsifier, 0.2-5.0 parts of thickener, 0-10.0 parts of acidity regulator, 0-16.0 parts of diary fiber, 0-5.0 parts of edible flavouring agent, 0-1 part of nutrient and a proper amount of purified water. According to the invention, the problems of the compound design of the product for realizing the function of assisting in reducing blood fat and the and the function verification of the product are successively solved, the instability problem of the products caused by the addition of the raw materials is solved so that the products have normal flavor and stable quality within shelf life.
Description
Invention field
The present invention relates to compound liquid diary product of a kind of auxiliary lipid-lowering function and preparation method thereof, more particularly a kind of liquid diary product that reaches national health food auxiliary lipid-lowering function related request and preparation method thereof.
Background of invention
In Europe, there are every year 4000000 people to die from heart and angiocardiopathy approximately, promptly account for 46% of all causes of death.Nearly 1,700 ten thousand people die from heart disease and apoplexy (account for global death toll 1/3) in the whole world.The World Health Organization estimates that annual nearly 2,500 ten thousand people in the whole world die from heart disease to the year two thousand twenty.The expert thinks, 50% heart and angiocardiopathy can balanced nutritiously be prevented or avoid through corresponding.
The correlative factor that causes heart disease has: smoking, excessive stress, autoimmunity decline, diabetes, obesity, hypertension and high fat of blood, high cholesterol.
In China, coronary heart disease death number in 2002 surpasses 700,000 people, is only second to India, occupies the whole world second.Health surveies in 2004 of ministry of Health of China show: hyperlipemic patients 1.6 hundred million people, and hyperpietic 1.6 hundred million people, overweight person 22% is grown up.According to scholarly forecast, the every rising 1mmol/L of the average T-CHOL in Asia, the dead probability that causes because of coronary heart disease will increase by 35%.According to WHO in 2000,1984 to 1999 in the period of, the average total cholesterol level in Pekinese rises to 5.25mmol/L for the male sex from 4.15mmol/L, rises to 5.10mmol/L for the women from 4.17mmol/l.
Dyslipidemia serious threat human health and life, it is the important risk factor that atherosclerotic lesion forms and makes progress, and has confirmed that lipid-regulation medicine can delay the generation of atherosclerotic event (like myocardium infarct and palsy).According to Chinese Medicine on July 30th, 2005: the clinical observation that people such as Internal Medicine-Cardiovascular Dept. director professor Qu Xiufen of Clinical Medicine College No.1, Harbin Medical Univ. carry out in the recent period confirms to regulate blood fat can significantly reduce cardiopathic M & M.
To comparing between Different Culture background crowd, can be clear that the relation between the morbidity of cholesterolemia and cardiovascular disease is proportionate.In the U.S. similar observed result is arranged also.The cholesterolemia concentration among the immigrant and the respective change of cardiovascular disease incidence have further confirmed above observed result.Clinical primary prevention test shows between the reduction amplitude of the decline degree of cholesterolemia concentration and lethal and non-lethality cardiovascular disease incidence direct relation is arranged.
A large amount of epidemiologic datas that exist about relation between cholesterolemia concentration and the dietary fat absorption.Can find out that from the research of seven states and the nearest MONICA result of study of classics crowd's average blood cholesterol levels is relevant with the shared percent of total of saturated fat of fat in the meals.
Alpha-linolenic acid has the effect of lipopenicillinase and norcholesterol equally as the precursor of EPA, DHA.Zoopery shows: feed the eucommia ulmoides seed oil that is rich in alpha-linolenic acid to rat; The cholesterol in serum of rat (TC), triglycerides (TG), low-density lipoprotein (LDL-C) all significantly are lower than (P＜0.05) in the lard group; TG also is lower than (P＜0.05) in the basal feed group, and the ratio of HDL and TC (HDL-D/TC) is then apparently higher than in the lard group.
Phytosterin ester is to utilize soybean wet goods vegetable oil cut or Tall oil to be raw material, obtains phytosterol through technologies such as saponification, extraction, crystallizations, then phytosterol and sunflower oil aliphatic acid is carried out esterification production and obtains.
Phytosterin ester becomes phytosterol, the similar cholesterol of phytosterol chemical constitution after getting into human body.In the human consumption process, phytosterol can replace the position of cholesterol in human body intestinal canal fat micelle, reduces the absorption of cholesterol in human body intestinal canal, increases the drainage of cholesterol, thereby reaches protection health of heart and the purpose that reduces coronary heart disease.
CN 101642167A has mentioned a kind of liquid dairy products that contains linoleic acid plus linolenic acid; Comprise 4-6 part leukotrienes, wherein mention " in changing batch can, squeeze into the part pasteurize milk, the rising temperature is to 55-60 ℃; add vegetable oil, leukotrienes, nutrient two; emulsifying agent, adopts to have shearing, and the agitator of mixed and dispersed effect stirred 15-20 minute " in preparation method's step.In this method, vegetable oil, leukotrienes stir under 60 ℃ of temperature and reach 15-20 minute, cause that very easily the aliphatic acid unsaturated bond is oxidized, and forfeiture raw material effect also produces fat oxidation local flavor beastly.
CN 101589740A has mentioned a kind of liquid diary product and production method thereof that contains phytosterol, comprises 0.9 ‰-18 ‰ phytosterol.In this method, functional raw material has only phytosterol and nutrient, and finished product can only realize reducing the function of cholesterol, can't be evaluated as to have " auxiliary antilipemic " function.
CN 101904356A has mentioned a kind of liquid milk and preparation method of nourishing heart, and comprises phytosterin ester 1.4 ‰-3.9 ‰, phosphatidase 10 .4 ‰-1 ‰.Its finished product can only be realized reducing the cholesterol function, safeguards health of heart, can't be evaluated as to have " auxiliary antilipemic " function.
CN 101258875A has mentioned a kind of reducing blood lipid yoghurt and preparation method, comprises phytosterin ester 13 ‰-50 ‰, fish oil 0.28 ‰-48 ‰.Its product only limits to yoghurt and cost of material is too high, is unfavorable for realizing.
According to above background information, the present invention finds a kind of functional raw material compound that can be applied in the liquid diary product, has solved in identical product, to realize reducing cholesterol and triglycerides index, realizes the purpose of reducing blood lipid.Guaranteed the stable of product.
Summary of the invention
The present invention includes following aspect:
1. compound liquid diary product comprises in the composition of raw materials of this compound liquid diary product:
Milk 300-996 weight portion,
Phytosterin ester 1.5-8 weight portion, 2-6 weight portion preferably, 3-5 weight portion more preferably, more preferably the 3.5-4.5 weight portion and
Linolenic oil 2-6 weight portion, preferably 2.5-5.5 weight portion, more preferably 3-5 weight portion, more preferably 3.5-4.5 weight portion.
2. according to item 1 described compound liquid diary product; Also comprise anti-oxidant 0.0001-3 weight portion in the composition of raw materials of this compound liquid diary product, preferred said anti-oxidant is one or more the combination that is selected from vitamin E, vitamin C, the D-sodium isoascorbate.
3. according to item 1 or 2 described compound liquid diary products; Also comprise emulsifying agent 0.3-3 weight portion in the composition of raw materials of this compound liquid diary product, preferred said emulsifying agent is one or more the combination that is selected from sucrose fatty ester, single stearic acid glycerine lipoprotein fat acid esters, diglycerine fatty acid ester, phosphatide and the polyglyceryl fatty acid ester.
4. according to each described compound liquid diary product in the item 1 to 3; Also comprise thickener 0.2-5 weight portion in the composition of raw materials of this compound liquid diary product, preferred thickener is one or more the combination that is selected from sodium carboxymethylcellulose, carragheen, gelatin, microcrystalline cellulose, gellan gum, xanthans, propylene glycol alginate, konjac glucomannan, agar, locust bean gum, guar gum and the pectin.
5. according to each described compound liquid diary product in the item 1 to 4; Also comprise acidity regulator 0.0001-10 weight portion in the composition of raw materials of this compound liquid diary product, preferred said acidity regulator is one or more the combination that is selected from natrium citricum, sodium pyrophosphate, sodium dihydrogen phosphate, sodium hydrogen phosphate, sodium phosphate trimer, calgon, potassium dihydrogen phosphate, calcium dihydrogen phosphate, the tertiary sodium phosphate.
6. according to each described compound liquid diary product in the item 1 to 5; Also comprise dietary fiber 0.0001-16 weight portion in the composition of raw materials of this compound liquid diary product, preferred said dietary fiber is one or more the combination that is selected from soluble dietary fiber, insoluble diedairy fiber.
7. according to each described compound liquid diary product in the item 1 to 6; Also comprise flavoring essence 0.0001-5 weight portion in the composition of raw materials of this compound liquid diary product, preferred flavoring essence is one or more the combination that is selected from sour milk essence, milk flavour, orange essence, grape essence, peach essence, cocoanut flavour, strawberry essence, lychee flavor, flavoring apple essence, honeydew melon essence, mango essence, passionflower essence, grapefruit essence, lemon extract, blueberry essence, pawpaw essence, flavoring banana essence, flavoring pineapple essence, tomato flavour, carrot essence, asparagus essence, spinach essence, apricot essence, Li Xiangjing, kiwi flavor, vanilla, flavoring rose essence, chocolate essence, walnut essence, wheat essence and cherry essence.
8. according to each described compound liquid diary product in the item 1 to 7; Also comprise nutrient 0.0001-1 weight portion in the composition of raw materials of this compound liquid diary product, preferred nutrient is to be selected from vitamin A, vitamin B complex, vitamin D, vitamin C, vitamin E, calcium lactate, taurine, folic acid, nicotinic acid, choline, ferrous sulfate, ironic citrate, zinc sulfate, zinc gluconate, sodium selenite, magnesium sulfate, magnesium gluconate, l-cn, lactoferrin, immunoglobulin (Ig), newborn mineral salt, ferrous sulfate, Ferric Sodium Edetate, ferric pyrophosphate, calcium carbonate, calcium gluconae, L-calcium lactate, calcium monohydrogen phosphate, zinc citrate, zinc acetate, zinc carbonate, sodium selenite, Se-enriched yeast, selenoprotein, selenide of carragheen, magnesium sulfate, magnesium carbonate, arachidonic acid, DHA, CPP etc. to one or more the combination in human body beneficial's the trace element.
9. compound liquid diary product, its composition of raw materials comprises:
10. according to the production method of each described compound liquid diary product among the item 1-9, this method comprises the milk that adds the 300-996 weight portion,
1.5-8 weight portion, 2-6 weight portion preferably, 3-5 weight portion more preferably, more preferably the phytosterin ester of 3.5-4.5 weight portion and
The 2-6 weight portion, 2.5-5.5 weight portion preferably, 3-5 weight portion more preferably, the step of the linolenic oil of 3.5-4.5 weight portion more preferably,
Wherein preferably, separately add phytosterin ester and linolenic oil.
According to the present invention, the compound liquid diary product and the production method thereof that contain phytosterin ester and linolenic oil are provided.Phytosterin ester and linolenic oil have cooperative effect, compare with the existing product type, and compound liquid diary product of the present invention has collaborative hypolipemic function.
The specific embodiment
First aspect of the present invention is:
A kind of compound liquid diary product comprises in the composition of raw materials of this compound liquid diary product:
Milk 300-996 weight portion
Phytosterin ester 1.5-8 weight portion and
Linolenic oil 2-6 weight portion.
Second aspect of the present invention is:
The production method of compound liquid diary product, this method comprise the step of linolenic oil of phytosterin ester and the 2-6 weight portion of the milk that adds the 300-996 weight portion, 1.5-8 weight portion.
As do not have specified otherwise, the implication of the scientific and technical terminology in this specification is identical with the general implication of understanding of those skilled in the art, but if any conflict, then is as the criterion with the definition in this specification.
In this specification, when relating to the compound liquid diary product, term " raw material " is meant the material that will add in the system, and raw material comprises being added into the material in the system in any step of producing at the compound liquid diary product (before for example sterilizing, after the sterilization).
As not having specified otherwise, the percentage in this specification (%) all is weight percentage.
Product of the present invention
On the one hand; One object of the present invention is to provide a kind of compound liquid diary product that reaches national health food " auxiliary antilipemic " function related request; Be compound preparation particularly, reach liquid diary product prescription of blood fat reducing function and preparation method thereof with phytosterin ester, linolenic oil.
The invention provides a kind of compound liquid diary product (being called for short product of the present invention), comprise in the composition of raw materials of this compound liquid diary product:
Milk 300-996 weight portion
Phytosterin ester 1.5-8 weight portion and
Linolenic oil 2-6 weight portion.
Compound liquid diary product provided by the invention according to the difference of milk level in the formula for a product, can be modulation breast or milk beverage.The milk that provides mainly is meant raw milk that meets GB19301 or the recombined milk for preparing with milk powder, condensed milk among the present invention, can be raw milk, also can be half skimmed milk or skimmed milk.Generally speaking, the protein content in the said milk can be 0.3-20 weight %, more preferably 0.5-10 weight %, more preferably 1-7 weight %, more preferably 1.5-5 weight %, more preferably 2-4 weight %, more preferably 2.9-3.6 weight %.Among the present invention, to not restriction such as the source of milk, working condition.
Phytosterin ester of the present invention is meant and utilizes soybean oil, rapeseed oil, corn oil, sunflower seeds wet goods vegetable oil cut or Tall oil to be raw material; Obtain phytosterol through technologies such as saponification, extraction, crystallizations; Then phytosterol and sunflower oil aliphatic acid are carried out the phytosterin ester that esterification production obtains; Or utilize soybean oil, rapeseed oil, corn oil, sunflower seeds wet goods vegetable oil cut or Tall oil to be raw material; Make through explained hereafter such as saponification, extraction, crystallizations, without the phytosterol of esterification technique.The amount of phytosterin ester is the 1.5-8 weight portion, preferably 2-6 weight portion, more preferably 3-5 weight portion, more preferably 3.5-4.5 weight portion.
Linolenic oil of the present invention is meant that being rich in linolenic material with perilla herb oil, eucommia ulmoides seed oil, samara wet goods is that raw material is through extracting purifying or the not purified linolenic oil raw material that obtains.The amount of linolenic oil is the 2-6 weight portion, preferably 2.5-5.5 weight portion, more preferably 3-5 weight portion, preferably 3.5-4.5 weight portion.
In addition, also comprise anti-oxidant 0.0001-3 weight portion in the composition of raw materials of compound liquid diary product of the present invention.
Among the present invention, the kind of anti-oxidant not being had particular restriction, can be any anti-oxidant that allows to be used for dairy products, but preferably said anti-oxidant can be used in and prevents the linolenic oil oxidation.Preferably, said anti-oxidant is one or more the combination that is selected from vitamin E, vitamin C, the D-sodium isoascorbate.
In addition, also comprise emulsifying agent 0.3-3 weight portion in the composition of raw materials of compound liquid diary product of the present invention.
Among the present invention, emulsifying agent not being had particular restriction, can be any emulsifying agent and thickener that allows to be used for dairy products.Preferably, said emulsifying agent is one or more the combination that is selected from sucrose fatty ester, single stearic acid glycerine lipoprotein fat acid esters, diglycerine fatty acid ester, phosphatide and the polyglyceryl fatty acid ester.
In addition, also comprise thickener 0.2-5 weight portion in the composition of raw materials of compound liquid diary product of the present invention.
Among the present invention, thickener not being had particular restriction, can be any thickener that allows to be used for dairy products.Preferably, thickener is one or more the combination that is selected from sodium carboxymethylcellulose, carragheen, gelatin, microcrystalline cellulose, gellan gum, xanthans, propylene glycol alginate, konjac glucomannan, agar, locust bean gum, guar gum and the pectin.
In addition, also comprise acidity regulator 0.0001-10 weight portion in the composition of raw materials of compound liquid diary product of the present invention.
Among the present invention, acidity regulator not being had particular restriction, can be any acidity regulator that allows to be used for dairy products.Preferably, said acidity regulator is one or more the combination that is selected from natrium citricum, sodium pyrophosphate, sodium dihydrogen phosphate, sodium hydrogen phosphate, sodium phosphate trimer, calgon, potassium dihydrogen phosphate, calcium dihydrogen phosphate, the tertiary sodium phosphate.
In addition, also comprise dietary fiber 0.0001-16 weight portion in the composition of raw materials of compound liquid diary product of the present invention.
Among the present invention, dietary fiber not being had particular restriction, can be any dietary fiber that allows to be used for dairy products.Preferred said dietary fiber is one or more the combination that is selected from soluble dietary fiber, insoluble diedairy fiber.
In addition, also comprise flavoring essence 0.0001-5 weight portion in the composition of raw materials of compound liquid diary product of the present invention.
Among the present invention, flavoring essence not being had particular restriction, can be any flavoring essence that allows to be used for dairy products.Preferably, flavoring essence is one or more the combination that is selected from sour milk essence, milk flavour, orange essence, grape essence, peach essence, cocoanut flavour, strawberry essence, lychee flavor, flavoring apple essence, honeydew melon essence, mango essence, passionflower essence, grapefruit essence, lemon extract, blueberry essence, pawpaw essence, flavoring banana essence, flavoring pineapple essence, tomato flavour, carrot essence, asparagus essence, spinach essence, apricot essence, Li Xiangjing, kiwi flavor, vanilla, flavoring rose essence, chocolate essence, walnut essence, wheat essence and cherry essence.
In addition, also comprise nutrient 0.0001-1 weight portion in the composition of raw materials of compound liquid diary product of the present invention.
Among the present invention, nutrient not being had particular restriction, can be any nutrient that allows to be used for dairy products.Preferably, nutrient is to be selected from vitamin A, vitamin B complex, vitamin D, vitamin C, vitamin E, calcium lactate, taurine, folic acid, nicotinic acid, choline, ferrous sulfate, ironic citrate, zinc sulfate, zinc gluconate, sodium selenite, magnesium sulfate, magnesium gluconate, l-cn, lactoferrin, immunoglobulin (Ig), newborn mineral salt, ferrous sulfate, Ferric Sodium Edetate, ferric pyrophosphate, calcium carbonate, calcium gluconae, L-calcium lactate, calcium monohydrogen phosphate, zinc citrate, zinc acetate, zinc carbonate, sodium selenite, Se-enriched yeast, selenoprotein, selenide of carragheen, magnesium sulfate, magnesium carbonate, arachidonic acid, DHA, CPP etc. to one or more the combination in human body beneficial's the trace element.
One of the preferred implementation of compound liquid diary product of the present invention is for example descended.
Method of the present invention
On the one hand, the invention provides the production method (being called for short method of the present invention) of compound liquid diary product, this method comprises the step of linolenic oil of phytosterin ester and the 2-6 weight portion of the milk that adds the 300-996 weight portion, 1.5-8 weight portion.
The amount of phytosterin ester is the 1.5-8 weight portion, preferably 2-6 weight portion, more preferably 3-5 weight portion, more preferably 3.5-4.5 weight portion.
The amount of linolenic oil is the 2-6 weight portion, preferably 2.5-5.5 weight portion, more preferably 3-5 weight portion, more preferably 3.5-4.5 weight portion.
In one embodiment; The present invention provides a kind of preparation method of compound liquid diary product, through appropriate change material technology, adds in the warm milk after 50 ℃ of-80 ℃ of water-bath fusions of employing phytosterin ester; The alpha-linolenic acid high speed shear adds to≤15 ℃ of cold milks in; Further, realize that to phytosterin ester, linolenic oil be the maximum protection of compound preparation, guarantee the good taste and the shelf life internal stability of product through technologies such as quick homogeneous and pasteurize, ultra high temperature sterilizations.
Preferably, method of the present invention is used for the product of production the invention described above.
In above-mentioned production process, the component of the compound liquid diary product that obtains is following:
The known technology relevant with the present invention for example is recorded in " breast and dairy products technology ", Luo Chengxiang, and Chinese agriculture publishing house, second edition, 1999.10, quote it in this specification in full as a reference.
Embodiment
Reference examples 1
Contain the preparation of phytosterin ester cow's milk
Select following prescription:
The concrete operations of preparation process are following:
1. raw milk: derive from own pasture, meet GB 19301 regulations.
2. prepare burden
2.1. phytosterin ester fusion
Airtight barreled raw material was placed on before batching in 2-4 hour in 50-60 ℃ the constant water bath box and soaks (upper edge that water level can not surpass Raw material pail).After soak finishing, can feed intake after opening the liquid that bung inspection raw materials melt is homogeneous, clarification,, then cover tight bung and continue to soak, till complete fusion if do not melt to above-mentioned state.
2.2. change material
Stirring slowly is warmed up to 35-40 ℃; Open high speed mixer; Molten condition phytosterin ester, emulsifying agent, thickener, dietary fiber, flavorant, anti-oxidant are added, keep the raw material unanimity that is uniformly dispersed, be warmed up to 70-75 ℃ then; Under this temperature, kept 10-20 minute, raw material is fully dissolved.After cooling to 20 ℃, the process plate type heat exchanger squeezes into blending tank.
2.3. vitamin E dissolving
By prescription vitamin E is added linolenic oil, stir and made it abundant dissolving in 10-15 minute.
2.4. mix
Blending tank stirred 10-15 minute, and twice change material milk is fully mixed.
3. pasteurize operation
3.1. homogeneous
Homogenizing temperature is 55 ℃-80 ℃, and the homogeneous gross pressure is 150-170bar, and the one-level homogenization pressure is 120-150bar, and double-stage homogenization pressure is 30-40bar.
Explain: 1bar=0.1MPa.
3.2. flash distillation
Flash distillation (or falling film evaporation) adjustment product protein index >=3.3g/100g.
3.3. pasteurize
85 ℃ ± 2 ℃, the time is 15 seconds.
3.4. semi-finished product store
The semi-finished product storage temperature is 0 ℃-7 ℃.
4. UHTS
4.1. homogeneous
Homogenization pressure: gross pressure 220-240bar, first class pressure 180-200bar, secondary pressure 40-50bar.
Homogenizing temperature: 60 ℃-90 ℃.
4.2. sterilising temp
137 ℃ ± 2 ℃, the time is 4-6S (the VTIS sterilization machine is 142 ℃ ± 2 ℃); 2 ℃-25 ℃ of feeding temperatures.
5. sterile filling
Adopt Tetra Pak TBA22250S bottle placer to carry out can, 8 ℃-30 ℃ of filling temperatures.
6. insulation experiment
Product is put into 37 ℃ of heat rooms, carries out microorganism, acidity after 7 days and detects, and dispatches from the factory after qualified.
Hypolipemic function zoopery checking
1. animal and grouping
Get 50 of rats; Feed raising after 5 days with normal diet, weigh, get tail blood; Survey the basic value of serum triglyceride (TG), T-CHOL (TC), HDL-C (HDL-C); According to basic T-CHOL (TC) level rat is divided into 5 groups at random then, 10 every group, is respectively basic, normal, high three dose groups of sample, prophylaxis of hyperlipidemia model control group and distilled water blank group.Each dose groups according to dosage designs and gives test liquid, all feeds simultaneously and raises high lipid food; Model control group is fed and is raised high lipid food, and the blank group is fed and raised normal diet.Fed for 4 weeks continuously, weigh weekly.In off-test fasting 16 hours, get rat blood serum and survey each item blood lipids index.
2. raising condition
The SD male rat is 20-25 ℃ in temperature, and relative humidity is to raise in 40%～70% the laboratory barrier system.
3. dosage
The human body RD 500mL/ people/day of phytosterin ester milk (phytosterol ester content 160mg/100g); Because sample human body RD every day is bigger; So use other material compositions after the removal cow's milk; The human body RD is 4.394g/ people/day (with the 60kg batheroom scale), establishes 0.366g/kg, 0.732g/kg, three dose groups of 2.197g/kg (be equivalent to respectively human body recommended intake 5 times, 10 times, 30 times), and other establishes blank group and model contrast.Data are carried out variance analysis with SPSS15.0 software.
4. the result judges
Serum total cholesterol and triglycerides binomial index were positive during serum total cholesterol, triglycerides, three indexs of HDL-C detected, and this given the test agent auxiliary lipid-lowering function zoopery of decidable result is positive.
5. result
5.1. phytosterin ester milk is to the influence of mouse body weight
Visible by table 1, blank group and each dose groups are compared with model control group before the experiment, and body weight does not have significant difference.The experiment end; Blank group, low dose group, high dose group body weight are starkly lower than model control group body weight (blank group P＜0.01; Low dose group and high dose group P＜0.05); The weightening finish of blank group and each dose groups also is starkly lower than model control group weightening finish (blank group, low dose group, high dose group P＜0.01, middle dose groups P＜0.05).
Table 1: phytosterin ester milk is to the influence
of mouse body weight
Annotate: * and model control group compare, P＜0.01; ▲ compare P＜0.05 with model control group
5.2. influence to animal T-CHOL (TC)
Visible by table 2, the T-CHOL at each dose groups and model control group experiment end is higher than experiment preceding (P＜0.01).The T-CHOL of testing last blank group is starkly lower than the T-CHOL of model control group (P＜0.01); The T-CHOL of high dose group is starkly lower than the T-CHOL (P＜0.05) of model control group.
Table 2: to the influence
of animal T-CHOL (TC)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; * compare P＜0.05 with model control group.
5.3. influence to animal triglycerides (TG)
Visible by table 3 result, the triglycerides at each dose groups and model control group experiment end is apparently higher than experiment preceding (P＜0.05).The content of triglyceride of testing last blank group is starkly lower than the triglycerides of model control group (blank group P＜0.01), and low dose group, middle dose groups and high dose group content of triglyceride and model control group contrast difference be remarkable (P＞0.05) not.
The influence
of table 3 pair animal triglycerides (TG)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; * compare P＜0.01 with model control group;
5.4. influence to animal HDL-C (HDL-C)
Visible by table 4 result, each dose groups is tested the HDL at end all before experiment, before the HDL at model control group experiment end is starkly lower than and tests (P＜0.01).The HDL-C and the model control group of each dose groups of experiment end compare, apparently higher than model control group (P＜001).
Table 4: to the influence
of animal HDL-C (HDL-C)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; * compare P＜0.01 with model control group
6 conclusions
Test last model control group and compare with the blank group, T-CHOL obviously raises, triglycerides obviously raise (P＜0.01).Compare with model control group; Test last sample high dose group T-CHOL and be starkly lower than model control group (P＜0.05); Basic, normal, high dose groups triglycerides of sample and model control group difference with insignificance, each dose groups HDL-C of sample is apparently higher than model control group (P＜0.01).Think that phytosterin ester milk has the cholesterol of reduction function to rat.
Reference examples 2
Contain the preparation of linolenic oil milk
Select following prescription:
The concrete operations of preparation process are following:
1. raw milk: derive from own pasture, meet GB 19301 regulations.
2. prepare burden:
2.1. change material one
Stirring slowly is warmed up to 35-40 ℃, opens high speed mixer, and emulsifying agent, thickener, dietary fiber, flavorant, anti-oxidant are added; Keep the raw material unanimity that is uniformly dispersed; Be warmed up to 70-75 ℃ then, under this temperature, kept 10-20 minute, raw material is fully dissolved.After cooling to 20 ℃, the process plate type heat exchanger squeezes into blending tank.
2.4. change material two
Change a certain amount of raw milk of adding in the batch can at another, the unlatching high speed mixer joins linolenic oil in the raw milk, stirs raw material to be well-dispersed in the cow's milk in 10-15 minute.Squeeze into blending tank.
2.5. mix
Blending tank stirred 10-15 minute, and twice change material milk is fully mixed.
3. pasteurize operation
3.1. homogeneous
Homogenizing temperature is 55 ℃-80 ℃, and the homogeneous gross pressure is 150-170bar, and the one-level homogenization pressure is 120-150bar, and double-stage homogenization pressure is 30-40bar.
Explain: 1bar=0.1MPa.
3.2. flash distillation
Flash distillation (or falling film evaporation) adjustment product protein index >=3.3g/100g.
3.3. pasteurize
85 ℃ ± 2 ℃, the time is 15 seconds.
3.4. semi-finished product store
The semi-finished product storage temperature is 0 ℃-7 ℃.
4. UHTS
4.1. homogeneous
Homogenization pressure: gross pressure 220-240bar, first class pressure 180-200bar, secondary pressure 40-50bar.
Homogenizing temperature: 60 ℃-90 ℃.
4.2. sterilising temp
137 ℃ ± 2 ℃, the time is 4-6S (the VTIS sterilization machine is 142 ℃ ± 2 ℃); 2 ℃-25 ℃ of feeding temperatures.
5. sterile filling
Adopt Tetra Pak TBA22250S bottle placer to carry out can, 8 ℃-30 ℃ of filling temperatures.
6. insulation experiment
Product is put into 37 ℃ of heat rooms, carries out microorganism, acidity after 7 days and detects, and dispatches from the factory after qualified.
Hypolipemic function zoopery checking
1. animal and grouping
Get 50 of rats; Feed raising after 5 days with normal diet, weigh, get tail blood; Survey the basic value of serum triglyceride (TG), T-CHOL (TC), HDL-C (HDL-C); According to basic T-CHOL (TC) level rat is divided into 5 groups at random then, 10 every group, is respectively basic, normal, high three dose groups of sample, prophylaxis of hyperlipidemia model control group and distilled water blank group.Each dose groups according to dosage designs and gives test liquid, all feeds simultaneously and raises high lipid food; Model control group is fed and is raised high lipid food, and the blank group is fed and raised normal diet.Fed for 4 weeks continuously, weigh weekly.In off-test fasting 16 hours, get rat blood serum and survey each item blood lipids index.
2. raising condition
The SD male rat is 20-25 ℃ in temperature, and relative humidity is to raise in the laboratory barrier system of 40%-70%.
3. dosage
The human body RD 500mL/ people/day of linolenic oil milk (alpha-linolenic acid content 160mg/100g); Because sample human body RD every day is bigger; So use other material compositions after the removal cow's milk; The human body RD is 4.394g/ people/day (with the 60kg batheroom scale), establishes 0.366g/kg, 0.732g/kg, three dose groups of 2.197g/kg (be equivalent to respectively human body recommended intake 5 times, 10 times, 30 times), and other establishes blank group and model contrast.Data are carried out variance analysis with SPSS15.0 software.
4. the result judges
Serum total cholesterol and triglycerides binomial index were positive during serum total cholesterol, triglycerides, three indexs of HDL-C detected, and this given the test agent auxiliary lipid-lowering function zoopery of decidable result is positive.
5. result
5.1. linolenic oil milk is to the influence of mouse body weight
Visible by table 5, blank group and each dose groups are compared with model control group before the experiment, and body weight does not have significant difference.The experiment end; Blank group, low dose group, high dose group body weight are starkly lower than model control group body weight (blank group P＜0.01; Low dose group and high dose group P＜0.05); The weightening finish of blank group and each dose groups also is starkly lower than model control group weightening finish (blank group, low dose group, high dose group P＜0.01, middle dose groups P＜0.05).
Table 5 linolenic oil milk is to the influence
of mouse body weight
Annotate: * and model control group compare, P＜0.01; ▲ compare P＜0.05 with model control group
5.2. influence to animal T-CHOL (TC)
Visible by table 6, the T-CHOL at each dose groups and model control group experiment end is higher than experiment preceding (P＜0.01).The T-CHOL of testing last blank group is starkly lower than the T-CHOL of model control group (P＜0.01); The T-CHOL of high dose group is starkly lower than the T-CHOL (P＜0.05) of model control group.
The influence
of table 6 pair animal T-CHOL (TC)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; * compare P＜0.05 with model control group.
5.3. influence to animal triglycerides (TG)
Visible by table 7 result, the triglycerides at each dose groups and model control group experiment end is apparently higher than experiment preceding (P＜0.01).The content of triglyceride of testing last blank group, middle dose groups, high dose group is starkly lower than the triglycerides of model control group (blank group P＜0.01, middle dose groups and high dose group P＜005).
The influence
of table 7 pair animal triglycerides (TG)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; # is with comparing P＜0.05 before and after the group experiment; * compare P＜0.01 with model control group; ▲ compare P＜0.05 with model control group.
5.4. influence to animal HDL-C (HDL-C)
Visible by table 8 result, difference not significantly (P＞0.05) before the HDL at each dose groups experiment end and the experiment.The HDL-C and the model control group of each dose groups of experiment end compare, and difference is remarkable (P＞0.05) not.
The influence
of table 8 pair animal HDL-C (HDL-C)
6. conclusion
Test last model control group and compare with the blank group, T-CHOL obviously raises, triglycerides obviously raise (P＜0.01).Compare with model control group; Test last sample high dose group T-CHOL and be starkly lower than model control group (P＜0.05); Sample is high, middle dose groups triglycerides is starkly lower than model control group (P＜0.05), and each dose groups HDL-C of sample and model control group difference is remarkable (P＞0.05) not.Think that linolenic oil milk has auxiliary lipid-lowering function to rat.
Embodiment 1
The preparation of high protein auxiliary antilipemic milk
Prescription:
Concrete preparation process is following:
1. raw milk: derive from own pasture, meet GB 19301 regulations.
2. prepare burden:
2.1. phytosterin ester fusion:
Airtight barreled raw material was placed on before batching in 2-4 hour in 50-60 ℃ the constant water bath box and soaks (upper edge that water level can not surpass Raw material pail).After soak finishing, can feed intake after opening the liquid that bung inspection raw materials melt is homogeneous, clarification,, then cover tight bung and continue to soak, till complete fusion if do not melt to above-mentioned state.
2.2. change material one
Stirring slowly is warmed up to 35-40 ℃; Open high speed mixer; Molten condition phytosterin ester, emulsifying agent, thickener, dietary fiber, flavorant, anti-oxidant are added, keep the raw material unanimity that is uniformly dispersed, be warmed up to 70-75 ℃ then; Under this temperature, kept 10-20 minute, raw material is fully dissolved.After cooling to 20 ℃, the process plate type heat exchanger squeezes into blending tank.
2.3. vitamin E dissolving:
By prescription vitamin E is added linolenic oil, stir and made it abundant dissolving in 10-15 minute.
2.4. change material two
Change a certain amount of raw milk of adding in the batch can at another, the unlatching high speed mixer joins linolenic oil in the raw milk, stirs raw material to be well-dispersed in the cow's milk in 10-15 minute.Squeeze into blending tank.
2.5. mix
Blending tank stirred 10-15 minute, and twice change material milk is fully mixed.
3. pasteurize operation
3.1. homogeneous
Homogenizing temperature is 55 ℃-80 ℃, and the homogeneous gross pressure is 150-170bar, and the one-level homogenization pressure is 120-150bar, and double-stage homogenization pressure is 30-40bar.
Explain: 1bar=0.1MPa.
3.2. flash distillation
Flash distillation (or falling film evaporation) adjustment product protein index (>=3.3g/100g).
3.3. pasteurize
85 ℃ ± 2 ℃, the time is 15 seconds.
3.4. semi-finished product store
The semi-finished product storage temperature is 0 ℃-7 ℃.
4. UHTS
4.1. homogeneous
Homogenization pressure: gross pressure 220-240bar, first class pressure 180-200bar, secondary pressure 40-50bar.
Homogenizing temperature: 60 ℃-90 ℃.
4.2 sterilising temp
137 ℃ ± 2 ℃, the time is 4-6S (the VTIS sterilization machine is 142 ℃ ± ℃); 2 ℃-25 ℃ of feeding temperatures.
5. sterile filling
Adopt Tetra Pak TBA22250S bottle placer to carry out can, 8 ℃-30 ℃ of filling temperatures.
6 insulation experiments
Product is put into 37 ℃ of heat rooms, carries out microorganism, acidity after 7 days and detects, and dispatches from the factory after qualified.
Hypolipemic function zoopery checking
1. animal and grouping
Get 50 of rats;, weigh after 5 days with the normal diet raising, get tail blood; Survey the basic value of serum triglyceride (TG), T-CHOL (TC), HDL-C (HDL-C); According to basic T-CHOL (TC) level rat is divided into 5 groups at random then, 10 every group, is respectively basic, normal, high three dose groups of sample, prophylaxis of hyperlipidemia model control group and distilled water blank group.Each dose groups according to dosage designs and gives test liquid, all feeds simultaneously and raises high lipid food; Model control group is fed and is raised high lipid food, and the blank group is fed and raised normal diet.Fed for 4 weeks continuously, weigh weekly.In off-test fasting 16 hours, get rat blood serum and survey each item blood lipids index.
2. raising condition
The SD male rat is 20-25 ℃ in temperature, and relative humidity is to raise in the laboratory barrier system of 40%-70%.
3. dosage
Phytosterin ester, alpha-linolenic acid compound milk (alpha-linolenic acid content 160mg/100g; Phytosterol ester content 160mg/100g) human body RD is 500mL/ people/day; Because sample human body RD every day is bigger; So use other material compositions after the removal cow's milk; The human body RD is that the human body RD that is converted to raw meal 6.394g/ people/day is 6.334g/ people/day (with the 60kg batheroom scale); If 0.533g/kg, 1.066g/kg, three dose groups of 3.197g/kg (be equivalent to respectively human body recommended intake 5 times, 10 times, 30 times), other establishes blank group and model contrast.Data are carried out variance analysis with SPSS15 software.
4. the result judges
Serum total cholesterol and triglycerides binomial index were positive during serum total cholesterol, triglycerides, three indexs of HDL-C detected, and this given the test agent auxiliary lipid-lowering function zoopery of decidable result is positive.
5. result
5.1. phytosterin ester, alpha-linolenic acid compound milk are to the influence of mouse body weight
Visible by table 9, blank group and each dose groups are compared with model control group before the experiment, and body weight does not have significant difference.The experiment end; Blank group, low dose group, high dose group body weight are starkly lower than model control group body weight (blank group P＜0.01; Low dose group and high dose group P＜0.05); The weightening finish of blank group and each dose groups also is starkly lower than model control group weightening finish (blank group, low dose group, high dose group P＜0.01, middle dose groups P＜0.05).
Table 9: phytosterin ester, alpha-linolenic acid compound milk are to the influence
of mouse body weight
Annotate: * and model control group compare, P＜0.01; ▲ compare P＜0.05 with model control group
5.2. influence to animal T-CHOL (TC)
Visible by table 10, each dose groups and model control group (P＜0.01) before the T-CHOL at experiment end is higher than experiment.The T-CHOL of testing last blank group and high dose group is starkly lower than the T-CHOL of model control group (P＜0.01).
Table 10: to the influence
of animal T-CHOL (TC)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; * compare P＜0.01 with model control group
5.3. influence to animal triglycerides (TG)
Visible by table 11 result, each dose groups and model control group are in the content of triglyceride at experiment end (low dose group and high dose group P＜0.05, middle dose groups and model control group P＜0.01) before the experiment.The content of triglyceride of testing last blank group, low dose group, high dose group is starkly lower than the content of triglyceride of model control group (blank group P＜0.01, low dose group and high dose group P＜0.05).
Table 11: to the influence
of animal triglycerides (TG)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; # is with comparing P＜0.05 before and after the group experiment; * compare P＜0.01 with model control group; ▲ compare P＜0.05 with model control group
5.4. influence to animal HDL-C (HDL-C)
Visible by table 12 result, all before the experiment, the HDL at model control group experiment end is starkly lower than (P＜0.01) before the experiment to the HDL at each dose groups experiment end.Experiment each dose groups of end and model control group be HDL-C obviously higher (P＜0.01) relatively.
Table 12: to the influence
of animal HDL-C (HDL-C)
Annotate: ★ is with comparing P＜0.01 before and after the group experiment; * compare P＜0.01 with model control group
6. conclusion
Test last model control group and compare with the blank group, T-CHOL obviously raises, triglycerides obviously raise (P＜0.01).Compare with model control group; Test last sample high dose group T-CHOL and be starkly lower than model control group (P＜0.01); Sample high and low dose group triglycerides is starkly lower than model control group (P＜0.01), and each dose groups HDL-C of sample is apparently higher than model control group (P＜0.01).Think that alpha-linolenic acid, phytosterin ester compound milk have auxiliary lipid-lowering function to rat.
The reduction cholesterol that reference examples 1 single phytosterin ester, reference examples 2 linolenic oil milk play, reduce triglycerides, to the HDL-C impact effect all not as good as embodiment 1 lipid-lowering effect (P＜0.01).
Embodiment 2: the preparation of auxiliary antilipemic recombined milk
Prescription:
The concrete operations of preparation process are following:
1. raw milk: meet GB 19301 regulations.
2. prepare burden:
2.1. phytosterin ester fusion:
Airtight barreled raw material was placed on before batching in 2-4 hour in 50-60 ℃ the constant water bath box and soaks (upper edge that water level can not surpass Raw material pail).After soak finishing, can feed intake after opening the liquid that bung inspection raw materials melt is homogeneous, clarification,, then cover tight bung and continue to soak if do not melt to above-mentioned state.
2.2. change material one
Stirring is warming up to 45-50 ℃; With molten condition phytosterin ester, emulsifying agent, anti-oxidant, thickener, acidity regulator 85-90 ℃ (programming rate≤2 ℃/minute); Stirred 3-15 minute, raw material is fully dissolved, feed liquid is cooled to the adding of back below 20 ℃ material-compound tank.
2.3. vitamin E dissolving:
By prescription vitamin E is added linolenic oil, stir and made it abundant dissolving in 10-15 minute.
2.4. change material two
Change a certain amount of raw milk of adding in the batch can at another, the unlatching high speed mixer joins linolenic oil in the raw milk, stirs raw material to be well-dispersed in the cow's milk in 10-15 minute.Squeeze into blending tank.
2.5. mix
Blending tank stirred 10-15 minute, and twice change material milk is fully mixed.
2.6. constant volume
With industrial water feed liquid jacking material-compound tank and constant volume in the pipeline.After marking the quantity of feed liquid, need it is scaled quality according to the proportion of this product with volume.
3. pasteurize operation
3.1. homogeneous
Homogenizing temperature: 60-80 ℃, homogenization pressure: gross pressure 150-170bar, first class pressure 120-130bar, secondary pressure 40-50bar.
Explain: 1bar=0.1MPa
3.2. pasteurize
Crust kills 95 ± 2 ℃ of temperature, and the time is 15 seconds.
3.3. semi-finished product store
The semi-finished product storage temperature is 0 ℃-7 ℃.
3.4. add essence
When demarcating end, add essence; Carry out perfuming behind the ratio weighing essence of actual scalar quantity according to the interior feed liquid of surge tank (or treating tinning) in the prescription regulation; Behind the perfuming that the used container of perfuming is clean with the rinse of produced in small quantities water, rinse liquid is all joined in the surge tank (or treating tinning).
4. UHTS
4.1. homogeneous
Homogenization pressure: gross pressure 220-240bar, first class pressure 180-200bar, secondary pressure 40-50bar.
Homogenizing temperature: 60 ℃-90 ℃.
4.2. sterilising temp: 142 ± 2 ℃, the time is 4-6 second (annotating: if must cancelling of degassing tank arranged on the UHT machine); 2 ℃-25 ℃ of feeding temperatures.
5. sterile filling
Adopt Tetra Pak TBA19250 bottle placer to carry out can, 8 ℃-30 ℃ of filling temperatures.
6. insulation experiment
Product is put into 37 ℃ of heat rooms, carries out microorganism, acidity after 7 days and detects, and dispatches from the factory after qualified.Embodiment 3: the preparation of auxiliary antilipemic acidic beverages
Prescription:
The concrete operations of preparation process are following:
1. raw milk: meet GB 19301 regulations.
2. prepare burden:
2.1. phytosterin ester fusion:
Airtight barreled raw material was placed on before batching in 2-4 hour in 50-60 ℃ the constant water bath box and soaks (upper edge that water level can not surpass Raw material pail).After soak finishing, can feed intake after opening the liquid that bung inspection raw materials melt is homogeneous, clarification,, then cover tight bung and continue to soak if do not melt to above-mentioned state.
2.2. change material one
Change and add an amount of batching water (batching was not less than 1: 1 with the ratio of water) in the batch can; 8 ℃-25 ℃ of water temperatures are opened sugar dissolving kettle and are stirred, with molten condition phytosterin ester, emulsifying agent, anti-oxidant, thickener adding batch can successively; Add the back stirring fully and made its dissolving in 10-30 minute; Treat abundant dissolving, behind the even no obvious particle of detection, filter through 80-100 order filter; Beat through tubular type (or board-like) cooler again and pump into blending tank after being chilled to 2 ℃-15 ℃, all head into the residual feed liquid in the pipeline in the jar with a small amount of batching water.
2.3. change material two
Change a certain amount of raw milk of adding in the batch can at another, the unlatching high speed mixer joins linolenic oil in the raw milk, stirs raw material to be well-dispersed in the cow's milk in 10-15 minute.Squeeze into blending tank.
2.4. mix
Blending tank stirred 10-15 minute, and twice change material fully mixed.
2.5. acid adjustment
2.5.1. dissolving acid
In dissolving the acid jar, squeeze into acid 40-50 batching water (temperature is 8 ℃-25 ℃) doubly, open stirring, acid is added dissolve in the acid jar, add the back fully and stirred 10-30 minute, after fully dissolving, prepare spray acid.
2.5.2. spray acid
Connect acid spraying tube road and shower nozzle, and the position of adjustment shower nozzle, make spray orifice aim at the upper surface of feed liquid in the material-compound tank; Open the stirring of material-compound tank, open sour valve of spray and acid material pump again, through shower nozzle lentamente in material-compound tank spray add acid; Add the speed of acid through flow valve control, make acid solution evenly, atomizing ground is sprayed at that (the little spray orifice of each of shower nozzle will be bell mouth shape, makes acid solution after spray orifice sprays, be vaporific on the liquid level in the material-compound tank; Can not linearly spray), can not be sprayed onto a jar inwall.The semi-finished product spray acid time per ton is 2-4 minute, feed temperature in material-compound tank during spray acid≤20 ℃ (guaranteeing spray acid continuously, uninterrupted).After finishing, spray acid all heads into the residual acid solution in the pipeline in the material-compound tank with a small amount of batching water.
2.6. constant volume
After spray acid finishes, demarcate.If scalar quantity does not meet the batching standard, add an amount of batching water again and demarcate the quality of feed liquid in the material-compound tank (after marking the quantity of feed liquid, needing it is scaled quality) according to the proportion of yaourt product with volume.Demarcate and finish back stirring 10-20 minute, prepare sampling and detect.
3. pasteurize operation
3.1. homogeneous
60 ℃-80 ℃ of homogenizing temperatures, homogeneous gross pressure 150-170bar, first class pressure 120-130bar, secondary pressure 40-50bar.
3.2. pasteurize
85 ℃ ± 2 ℃, the time is 15 seconds.
3.3. semi-finished product store
The semi-finished product storage temperature is 0 ℃-7 ℃.
3.4. add essence
When demarcating end, add essence; Carry out perfuming behind the ratio weighing essence of actual scalar quantity according to the interior feed liquid of surge tank (or treating tinning) in the prescription regulation; Behind the perfuming that the used container of perfuming is clean with the rinse of produced in small quantities water, rinse liquid is all joined in the surge tank (or treating tinning).
4. UHTS
4.1. homogeneous
Homogenization pressure: gross pressure 190-200bar, first class pressure 150-160bar wherein, secondary pressure 35-40bar.Homogenizing temperature: 60 ℃-90 ℃.
4.2. sterilising temp: 121 ± 2 ℃ of times are 4-6S.
5. sterile filling
Adopt Tetra Pak A3250 bottle placer to carry out can, 8 ℃-30 ℃ of filling temperatures.
6. insulation experiment
Product is put into 37 ℃ of heat rooms, carries out microorganism, acidity after 7 days and detects, and dispatches from the factory after qualified.
Claims (10)
1. compound liquid diary product comprises in the composition of raw materials of this compound liquid diary product:
Milk 300-996 weight portion,
Phytosterin ester 1.5-8 weight portion, 2-6 weight portion preferably, 3-5 weight portion more preferably, more preferably the 3.5-4.5 weight portion and
Linolenic oil 2-6 weight portion, preferably 2.5-5.5 weight portion, more preferably 3-5 weight portion, more preferably 3.5-4.5 weight portion.
2. compound liquid diary product according to claim 1; Also comprise anti-oxidant 0.0001-3 weight portion in the composition of raw materials of this compound liquid diary product, preferred said anti-oxidant is one or more the combination that is selected from vitamin E, vitamin C, the D-sodium isoascorbate.
3. compound liquid diary product according to claim 1 and 2; Also comprise emulsifying agent 0.3-3 weight portion in the composition of raw materials of this compound liquid diary product, preferred said emulsifying agent is one or more the combination that is selected from sucrose fatty ester, single stearic acid glycerine lipoprotein fat acid esters, diglycerine fatty acid ester, phosphatide and the polyglyceryl fatty acid ester.
4. according to each described compound liquid diary product in the claim 1 to 3; Also comprise thickener 0.2-5 weight portion in the composition of raw materials of this compound liquid diary product, preferred thickener is one or more the combination that is selected from sodium carboxymethylcellulose, carragheen, gelatin, microcrystalline cellulose, gellan gum, xanthans, propylene glycol alginate, konjac glucomannan, agar, locust bean gum, guar gum and the pectin.
5. according to each described compound liquid diary product in the claim 1 to 4; Also comprise acidity regulator 0.0001-10 weight portion in the composition of raw materials of this compound liquid diary product, preferred said acidity regulator is one or more the combination that is selected from natrium citricum, sodium pyrophosphate, sodium dihydrogen phosphate, sodium hydrogen phosphate, sodium phosphate trimer, calgon, potassium dihydrogen phosphate, calcium dihydrogen phosphate, the tertiary sodium phosphate.
6. according to each described compound liquid diary product in the claim 1 to 5; Also comprise dietary fiber 0.0001-16 weight portion in the composition of raw materials of this compound liquid diary product, preferred said dietary fiber is one or more the combination that is selected from soluble dietary fiber, insoluble diedairy fiber.
7. according to each described compound liquid diary product in the claim 1 to 6; Also comprise flavoring essence 0.0001-5 weight portion in the composition of raw materials of this compound liquid diary product, preferred flavoring essence is one or more the combination that is selected from sour milk essence, milk flavour, orange essence, grape essence, peach essence, cocoanut flavour, strawberry essence, lychee flavor, flavoring apple essence, honeydew melon essence, mango essence, passionflower essence, grapefruit essence, lemon extract, blueberry essence, pawpaw essence, flavoring banana essence, flavoring pineapple essence, tomato flavour, carrot essence, asparagus essence, spinach essence, apricot essence, Li Xiangjing, kiwi flavor, vanilla, flavoring rose essence, chocolate essence, walnut essence, wheat essence and cherry essence.
8. according to each described compound liquid diary product in the claim 1 to 7; Also comprise nutrient 0.0001-1 weight portion in the composition of raw materials of this compound liquid diary product, preferred nutrient is to be selected from vitamin A, vitamin B complex, vitamin D, vitamin C, vitamin E, calcium lactate, taurine, folic acid, nicotinic acid, choline, ferrous sulfate, ironic citrate, zinc sulfate, zinc gluconate, sodium selenite, magnesium sulfate, magnesium gluconate, l-cn, lactoferrin, immunoglobulin (Ig), newborn mineral salt, ferrous sulfate, Ferric Sodium Edetate, ferric pyrophosphate, calcium carbonate, calcium gluconae, L-calcium lactate, calcium monohydrogen phosphate, zinc citrate, zinc acetate, zinc carbonate, sodium selenite, Se-enriched yeast, selenoprotein, selenide of carragheen, magnesium sulfate, magnesium carbonate, arachidonic acid, DHA, CPP etc. to one or more the combination in human body beneficial's the trace element.
9. compound liquid diary product, its composition of raw materials comprises:
10. according to the production method of each described compound liquid diary product among the claim 1-9, this method comprises the milk that adds the 300-996 weight portion,
1.5-8 weight portion, 2-6 weight portion preferably, 3-5 weight portion more preferably, more preferably the phytosterin ester of 3.5-4.5 weight portion and
The 2-6 weight portion, 2.5-5.5 weight portion preferably, 3-5 weight portion more preferably, the step of the linolenic oil of 3.5-4.5 weight portion more preferably,
Wherein preferably, separately add phytosterin ester and linolenic oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101126756A CN102630754A (en) | 2012-04-18 | 2012-04-18 | Compound liquid dairy product with function of assisting in reducing blood fat and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101126756A CN102630754A (en) | 2012-04-18 | 2012-04-18 | Compound liquid dairy product with function of assisting in reducing blood fat and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102630754A true CN102630754A (en) | 2012-08-15 |
Family
ID=46615472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101126756A Pending CN102630754A (en) | 2012-04-18 | 2012-04-18 | Compound liquid dairy product with function of assisting in reducing blood fat and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102630754A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102948483A (en) * | 2012-12-03 | 2013-03-06 | 内蒙古伊利实业集团股份有限公司 | Blood fat reducing milk powder and preparation method thereof |
| CN103859021A (en) * | 2012-12-11 | 2014-06-18 | 河北三元食品有限公司 | Heart nourishing milk product with stable quality, and preparation method thereof |
| CN104255916A (en) * | 2014-09-18 | 2015-01-07 | 印天寿 | Selenium-enriched yogurt and family preparation method of selenium-enriched yogurt |
| CN105265584A (en) * | 2014-07-18 | 2016-01-27 | 内蒙古伊利实业集团股份有限公司 | Cardio-cerebral blood vessel health improving liquid state dairy product and production method thereof |
| CN107960662A (en) * | 2017-11-03 | 2018-04-27 | 嘉必优生物技术（武汉）股份有限公司 | A kind of health products with hypolipemic function and preparation method thereof |
| CN109479969A (en) * | 2018-10-30 | 2019-03-19 | 徐州汇尔康食品有限公司 | A kind of compound liquid diary product |
| CN109479968A (en) * | 2018-10-30 | 2019-03-19 | 徐州汇尔康食品有限公司 | A kind of liquid diary product containing phytosterol |
| CN111248281A (en) * | 2018-11-30 | 2020-06-09 | 内蒙古伊利实业集团股份有限公司 | Method for adding milk mineral salt into yoghourt, jam containing milk mineral salt and yoghourt |
| CN111602720A (en) * | 2020-05-11 | 2020-09-01 | 呼伦贝尔双娃乳业有限公司 | Formula milk powder for middle-aged and old people |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1397180A (en) * | 2001-07-13 | 2003-02-19 | 池田食研株式会社 | Sterol aliphatic ester compsns. and foods contg. same |
| CN1830273A (en) * | 2006-04-19 | 2006-09-13 | 内蒙古蒙牛乳业（集团）股份有限公司 | Method of producing liquid milk product |
| CN1913874A (en) * | 2004-02-10 | 2007-02-14 | 嘉吉有限公司 | Particulate plant sterol compositions |
| CN101243811A (en) * | 2008-03-21 | 2008-08-20 | 内蒙古伊利实业集团股份有限公司 | Milk product for reinforcing phytosterin ester and producing method thereof |
| CN101589740A (en) * | 2008-05-30 | 2009-12-02 | 内蒙古伊利实业集团股份有限公司 | The liquid diary product and the production method thereof that contain phytosterol |
| CN101642167A (en) * | 2008-08-07 | 2010-02-10 | 内蒙古伊利实业集团股份有限公司 | Liquid dairy product containing linoleic acid and linolenic acid and preparation method thereof |
| CN101874521A (en) * | 2009-11-13 | 2010-11-03 | 内蒙古伊利实业集团股份有限公司 | Liquid dairy product containing haw pulp and ginger juice and producing method thereof |
-
2012
- 2012-04-18 CN CN2012101126756A patent/CN102630754A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1397180A (en) * | 2001-07-13 | 2003-02-19 | 池田食研株式会社 | Sterol aliphatic ester compsns. and foods contg. same |
| CN1913874A (en) * | 2004-02-10 | 2007-02-14 | 嘉吉有限公司 | Particulate plant sterol compositions |
| CN1830273A (en) * | 2006-04-19 | 2006-09-13 | 内蒙古蒙牛乳业（集团）股份有限公司 | Method of producing liquid milk product |
| CN101243811A (en) * | 2008-03-21 | 2008-08-20 | 内蒙古伊利实业集团股份有限公司 | Milk product for reinforcing phytosterin ester and producing method thereof |
| CN101589740A (en) * | 2008-05-30 | 2009-12-02 | 内蒙古伊利实业集团股份有限公司 | The liquid diary product and the production method thereof that contain phytosterol |
| CN101642167A (en) * | 2008-08-07 | 2010-02-10 | 内蒙古伊利实业集团股份有限公司 | Liquid dairy product containing linoleic acid and linolenic acid and preparation method thereof |
| CN101874521A (en) * | 2009-11-13 | 2010-11-03 | 内蒙古伊利实业集团股份有限公司 | Liquid dairy product containing haw pulp and ginger juice and producing method thereof |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102948483A (en) * | 2012-12-03 | 2013-03-06 | 内蒙古伊利实业集团股份有限公司 | Blood fat reducing milk powder and preparation method thereof |
| CN103859021A (en) * | 2012-12-11 | 2014-06-18 | 河北三元食品有限公司 | Heart nourishing milk product with stable quality, and preparation method thereof |
| CN103859021B (en) * | 2012-12-11 | 2018-07-24 | 河北三元食品有限公司 | A kind of the nourishing heart dairy produce and preparation method of stay in grade |
| CN105265584A (en) * | 2014-07-18 | 2016-01-27 | 内蒙古伊利实业集团股份有限公司 | Cardio-cerebral blood vessel health improving liquid state dairy product and production method thereof |
| CN104255916A (en) * | 2014-09-18 | 2015-01-07 | 印天寿 | Selenium-enriched yogurt and family preparation method of selenium-enriched yogurt |
| CN107960662A (en) * | 2017-11-03 | 2018-04-27 | 嘉必优生物技术（武汉）股份有限公司 | A kind of health products with hypolipemic function and preparation method thereof |
| CN109479969A (en) * | 2018-10-30 | 2019-03-19 | 徐州汇尔康食品有限公司 | A kind of compound liquid diary product |
| CN109479968A (en) * | 2018-10-30 | 2019-03-19 | 徐州汇尔康食品有限公司 | A kind of liquid diary product containing phytosterol |
| CN111248281A (en) * | 2018-11-30 | 2020-06-09 | 内蒙古伊利实业集团股份有限公司 | Method for adding milk mineral salt into yoghourt, jam containing milk mineral salt and yoghourt |
| CN111602720A (en) * | 2020-05-11 | 2020-09-01 | 呼伦贝尔双娃乳业有限公司 | Formula milk powder for middle-aged and old people |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102630754A (en) | Compound liquid dairy product with function of assisting in reducing blood fat and preparation method thereof | |
| CN102144669B (en) | DHASCO (docosahexaenoic acid single cell oil)-contained modulated milk and production method thereof | |
| CN103082000A (en) | Low-lactose liquid milk product containing fish oil and production method thereof | |
| TW200529864A (en) | Method for producing maca extract | |
| CN102106382B (en) | Recovery sports dairy product and preparation method thereof | |
| CN104222279A (en) | Brown sour milk beverage containing real fruit variants and production method thereof | |
| CN102047959A (en) | Yoghurt containing fruit vinegar and preparation method thereof | |
| CN102742891A (en) | Loquat fruit juice beverage and production process thereof | |
| CN102028034A (en) | Acid anti-oxidation liquid dairy product and preparation method thereof | |
| CN104839331A (en) | Fermentation participated dietary fiber and non-fat lactic acid bacteria beverage with a long quality guarantee period | |
| CN108085234A (en) | A kind of preparation method of roxburgh rose vinegar beverage | |
| CN102318677B (en) | Blended milk beverage added with xylooligosaccharide produced by enzyme hydrolysis technology | |
| CN104188015B (en) | A kind of Woman's health-care beverage prepared by Flos Camelliae sinensis and pueraria root powder | |
| CN102422883A (en) | Yoghourt with ginger extract and preparation method thereof | |
| CN103859039B (en) | It is of value to the fluid milk composition improving immunization programs for children power | |
| CN104450357A (en) | Method for brewing red date wine | |
| CN105519680A (en) | Liquid dairy product containing vegetable oil and production method thereof | |
| CN102524402B (en) | Liquid milk product containing phosphatidylserine | |
| CN107960464A (en) | A kind of high protein low fat liquid diary product and preparation method thereof | |
| CN102405976A (en) | Sour flavored milk-containing beverage containing ginger extract and preparation method thereof | |
| CN101406218B (en) | Liquid dairy food containing fish oil and method for producing the same | |
| CN102550681B (en) | Liquid dairy product added with marine collagen oligopeptide and preparation method thereof | |
| JP5327816B2 (en) | New use of genistein | |
| CN102138585B (en) | Resveratrol-added dairy product and preparation method thereof | |
| CN101406219B (en) | Method for producing liquid state dairy product containing fish oil and products thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120815 |